Cytomegalovirus Disease: Fine-Tuning Clinical Trial Enrollment and Standardization

Clin Infect Dis. 2024 Sep 26;79(3):795-796. doi: 10.1093/cid/ciae319.

Authors

Jennifer M Cuellar-Rodriguez¹, David van Duin²

Affiliations

¹ Transplant Infectious Diseases, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
² Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antiviral Agents / therapeutic use
Clinical Trials as Topic* / standards
Cytomegalovirus
Cytomegalovirus Infections* / drug therapy
Humans
Patient Selection

Substances

Antiviral Agents

Grants and funding

Division of Intramural Research, National Institute of Allergy and Infectious Diseases